[Federal Register Volume 70, Number 77 (Friday, April 22, 2005)]
[Notices]
[Page 20915]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-8090]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


A Public Health Action Plan To Combat Antimicrobial Resistance 
(Part I: Domestic Issues); Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report

    The Centers for Disease Control and Prevention (CDC), Food and Drug 
Administration (FDA), and National Institutes of Health (NIH) announce 
an open meeting concerning antimicrobial resistance.
    Name: ``A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues)'': Meeting for Public Comment on 
the Antimicrobial Resistance Interagency Task Force Annual Report.
    Time and Date: 1:30 p.m.-5 p.m., June 29, 2005.
    Place: Hyatt Regency Bethesda, Haverford/Baccarat Suite, One 
Bethesda Metro Center, 7400 Wisconsin Avenue at Old Georgetown Road, 
Bethesda, Maryland, 20814; Telephone: 1-301-657-1234; Fax: 1-301-657-
6453.
    Status: Open to the public, limited by the space available.
    Purpose: To present the third annual report of progress by Federal 
agencies in accomplishing activities outlined in ``A Public Health 
Action Plan to Combat Antimicrobial Resistance (Part I: Domestic 
Issues),'' and solicit comments from the public regarding the annual 
report. The Action Plan serves as a blueprint for activities of Federal 
agencies to address antimicrobial resistance. The focus of the plan is 
on domestic issues.
    Matters to be Discussed: The agenda will consist of welcome, 
introductory comments, followed by discussion of four focus areas in 
sequential plenary sessions lasting up to 45 minutes each. The four 
focus areas are: Surveillance, Prevention and Control, Research, and 
Product Development. Session leaders will give a 10 to 15 minute 
overview at the beginning of each session, then open the meeting for 
general discussion.
    Comments and suggestions from the public for Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsements of specific commercial products.
    The Action Plan, Annual Report, and meeting agenda will be 
available at http://www.cdc.gov/drugresistance. The public meeting is 
sponsored by the CDC, FDA, and NIH, in collaboration with seven other 
Federal agencies and departments involved in developing and writing ``A 
Public Health Action Plan to Combat Antimicrobial Resistance (Part I: 
Domestic Issues).''
    Agenda items are subject to change as priorities dictate.
    Limited time will be available for oral questions, comments, and 
suggestions from the public. Depending on the number wishing to 
comment, a time limit of three minutes may be imposed. In the interest 
of time, visual aids will not be permitted, although written material 
may be submitted to the Task Force. Written comments and suggestions 
from the public are encouraged and can be submitted at the meeting or 
should be received by the contact person (below) by regular mail or e-
mail listed below no later than July 31, 2005.
    Persons who anticipate attending the meeting are requested to send 
written notification to the contact person (below) by June 17, 2005, 
including name, organization (if applicable), address, phone, fax, and 
e-mail address.

FOR FURTHER INFORMATION CONTACT: Ms. Vickie Garrett, Antimicrobial 
Resistance, Office of the Director, NCID, CDC, mail stop C-12, 1600 
Clifton Road, NE., Atlanta, Georgia 30333; telephone 404-639-2603; fax 
404-639-4197; or e-mail [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 18, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-8090 Filed 4-21-05; 8:45 am]
BILLING CODE 4163-18-P